Trial Outcomes & Findings for Brief Restructuring Intervention Following Trauma Exposure (NCT NCT02808468)

NCT ID: NCT02808468

Last Updated: 2025-02-26

Results Overview

The Posttraumatic Stress Disorder Symptom Scale- Interview Version (PSS-I) assesses severity of symptoms of posttraumatic stress disorder (PTSD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) and is administered at baseline and 3 month follow up to assess change in PTSD symptoms. The range for the scale is 0-80 with higher scores representing more severe PTSD symptoms.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

57 participants

Primary outcome timeframe

12 weeks

Results posted on

2025-02-26

Participant Flow

Participant milestones

Participant milestones
Measure
Brief Cognitive Intervention
One in person session (90 minutes) of trauma focused cognitive therapy followed by 4 weekly coaching calls (20 minutes each) with the same study therapist Brief Cognitive Therapy: Cognitive strategies to help achieve balanced thinking around sexual assault and alcohol use
Assessment Only
Assessment session followed by weekly completion of assessment measures
Overall Study
STARTED
28
29
Overall Study
COMPLETED
21
27
Overall Study
NOT COMPLETED
7
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Brief Restructuring Intervention Following Trauma Exposure

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Brief Cognitive Intervention
n=28 Participants
One in person session (90 minutes) of trauma focused cognitive therapy followed by 4 weekly coaching calls (20 minutes each) with the same study therapist Brief Cognitive Therapy: Cognitive strategies to help achieve balanced thinking around sexual assault and alcohol use
Assessment Only
n=29 Participants
Assessment session followed by weekly completion of assessment measures
Total
n=57 Participants
Total of all reporting groups
Age, Continuous
21.1 years
STANDARD_DEVIATION 4 • n=99 Participants
22.1 years
STANDARD_DEVIATION 3.4 • n=107 Participants
21.6 years
STANDARD_DEVIATION 3.7 • n=206 Participants
Sex: Female, Male
Female
28 Participants
n=99 Participants
29 Participants
n=107 Participants
57 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=99 Participants
3 Participants
n=107 Participants
7 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants
n=99 Participants
26 Participants
n=107 Participants
50 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
8 Participants
n=99 Participants
5 Participants
n=107 Participants
13 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Race (NIH/OMB)
White
16 Participants
n=99 Participants
22 Participants
n=107 Participants
38 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=99 Participants
1 Participants
n=107 Participants
4 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
United States
28 Participants
n=99 Participants
29 Participants
n=107 Participants
57 Participants
n=206 Participants
PTSD Symptom Severity
32.4 score on a scale
STANDARD_DEVIATION 8.4 • n=99 Participants
33.2 score on a scale
STANDARD_DEVIATION 8.4 • n=107 Participants
32.8 score on a scale
STANDARD_DEVIATION 8.3 • n=206 Participants
Timeline Followback Heavy Episodic Drinking Episodes
5.4 episodes
STANDARD_DEVIATION 4.4 • n=99 Participants
5.8 episodes
STANDARD_DEVIATION 3.5 • n=107 Participants
5.6 episodes
STANDARD_DEVIATION 3.9 • n=206 Participants
Alcohol use negative consequences
17.7 score on a scale
STANDARD_DEVIATION 24.3 • n=99 Participants
19.8 score on a scale
STANDARD_DEVIATION 15.3 • n=107 Participants
18.74 score on a scale
STANDARD_DEVIATION 20.1 • n=206 Participants

PRIMARY outcome

Timeframe: 12 weeks

Population: Analyzed data from all participants assigned to each condition regardless of completion or missing data (intent to treat).

The Posttraumatic Stress Disorder Symptom Scale- Interview Version (PSS-I) assesses severity of symptoms of posttraumatic stress disorder (PTSD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) and is administered at baseline and 3 month follow up to assess change in PTSD symptoms. The range for the scale is 0-80 with higher scores representing more severe PTSD symptoms.

Outcome measures

Outcome measures
Measure
Brief Cognitive Intervention
n=28 Participants
One in person session (90 minutes) of trauma focused cognitive therapy followed by 4 weekly coaching calls (20 minutes each) with the same study therapist Brief Cognitive Therapy: Cognitive strategies to help achieve balanced thinking around sexual assault and alcohol use
Assessment Only
n=29 Participants
Assessment session followed by weekly completion of assessment measures
Posttraumatic Stress Disorder Symptom Scale- Interview Version (PSS-I)
11.4 score on a scale
Standard Deviation 7.0
22.1 score on a scale
Standard Deviation 10.4

PRIMARY outcome

Timeframe: 12 weeks

Population: Analyzed data from all participants assigned to each condition regardless of completion or missing data (intent to treat).

The Timeline Followback (TLFB) uses a calendar method with cued recall to assess frequency and quantity of alcoholic beverages consumed. Quantity of drinks are reported per day. Episodes of heavy episodic drinking (4+ drinks per occasion) are counted to calculate the number of HED episodes in the past month. The minimum score possible is 0 for number of HED episodes in the past month and the maximum is 30 (count of days in past 30 days in which HED occurred). Higher numbers indicate more heavy episodic drinking episodes.

Outcome measures

Outcome measures
Measure
Brief Cognitive Intervention
n=28 Participants
One in person session (90 minutes) of trauma focused cognitive therapy followed by 4 weekly coaching calls (20 minutes each) with the same study therapist Brief Cognitive Therapy: Cognitive strategies to help achieve balanced thinking around sexual assault and alcohol use
Assessment Only
n=29 Participants
Assessment session followed by weekly completion of assessment measures
Timeline Followback Heavy Episodic Drinking Episodes
2.2 episodes
Standard Deviation 2.7
3.7 episodes
Standard Deviation 3.7

SECONDARY outcome

Timeframe: 12 weeks

Population: Analyzed data from all participants assigned to each condition regardless of completion or missing data (intent to treat).

Total score of alcohol related negative consequences as reported on the self-report Drinking Inventory of Consequences (DrInC). The total range of scores is 0-135 and higher scores indicate more negative consequences of alcohol use. It is administered at baseline and 3-month follow-up to assess change in alcohol related consequences.

Outcome measures

Outcome measures
Measure
Brief Cognitive Intervention
n=28 Participants
One in person session (90 minutes) of trauma focused cognitive therapy followed by 4 weekly coaching calls (20 minutes each) with the same study therapist Brief Cognitive Therapy: Cognitive strategies to help achieve balanced thinking around sexual assault and alcohol use
Assessment Only
n=29 Participants
Assessment session followed by weekly completion of assessment measures
Drinking Inventory of Consequences (DrInC)
7.4 score on a scale
Standard Deviation 14.0
19.8 score on a scale
Standard Deviation 15.3

Adverse Events

Brief Cognitive Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Assessment Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Michele Bedard-Gilligan

University of Washington

Phone: 206-616-4215

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place